While other device-based closures have demonstrated notable rates of atrial fibrillation (5.7–6.6%) and device-related adverse events, the NobleStitch™ system's fully suture-mediated approach ...

Sahajanand Medical Technologies (SMT) is using its Cocoon Occluder devices to treat congenital heart defects like atrial septal defect and patent foramen ovale. These minimally invasive devices ...

King Faisal Hospital has successfully carried out Rwanda’s first percutaneous closure of a patent foramen ovale (PFO), a rare catheter-based heart procedure performed on a stroke patient. The ...

Flaherty & Crumrine Preferred Income Opportunity Fund remains a buy, offering a 6.3% yield and trading at a 6.54% discount to NAV. PFO provides diversified exposure to preferred securities, with a ...